Search Results

This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.

This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.

The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.

This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to...

This booklet is one of several culturally-appropriate patient education materials produced by the Centers for Disease Control and Prevention and the Northeastern National Tuberculosis Center. This booklet provides information on treatment for TB infection, treatment for TB disease, and how to stay...

This instructional packet includes a series of four print-based modules addressing TB contact investigation, case management, and confidentiality. It also provides information on managing multidrug-resistant TB and on DOT.

These educational modules are designed to provide basic information about tuberculosis (TB) in a self-study format for new TB health care workers. This instructional packet includes a series of five modules, an introduction, a glossary, and content covering transmission, pathogenesis, epidemiology...

This brochure lists the symptoms of active tuberculosis (TB) disease and includes directions for curing TB. It also provides drug information for treating TB and side effects that may occur from these medications.

This guideline is intended to provide a framework and understanding of the diagnostic approaches to TB infection/disease and to present a classification scheme that facilitates management of all persons who have had diagnostic tests.

This contract form is for persons who refuse TB care, given they have been informed about LTBI and TB disease.

This is a checklist agreement between clients and health care providers for their active tuberculosis (TB) treatment plan.